Why FactSet Research Systems (FDS) is Back on Investors’ Radar
FactSet Research Systems (FDS) has drawn fresh attention after recent trading left the shares around $227.68, with returns showing mixed signals across the past week, month, and past 3 months.
See our latest analysis for FactSet Research Systems.
The recent 14.8% 7 day share price return contrasts with a 20.1% decline year to date and a 44.5% 1 year total shareholder return loss. This suggests short term momentum after a tougher stretch for longer term holders.
If this kind of rebound has you thinking about where else momentum could appear next, it may be worth scanning 20 top founder-led companies
With FactSet trading at $227.68, an implied intrinsic discount of about 39%, solid annual revenue and net income, and a value score of 4, is the market offering a genuine entry point or already pricing in future growth?
Most Popular Narrative: 27.5% Undervalued
At a last close of $227.68 versus a narrative fair value of $313.99, the current price sits well below what this widely followed view considers reasonable, setting the stage for a very different picture of FactSet’s future earnings power.
At the current price of ~210 USD, the market is valuing FactSet as a certain victim of generative AI (“SaaSPocalypse”), completely ignoring the company’s structural transformation over the last 5 years. FactSet no longer sells just access to stock prices (which can be commoditized); it sells operational infrastructure built on four strategic pillars that are extremely hard for a chatbot to replace: Cobalt (Private Markets), CUSIP (Global Standards), Vermilion (Reporting), and Portware (Execution).
This narrative, according to SelectiveCapital, leans on a mix of recurring infrastructure revenues, firm margins and a future profit multiple that points to a very different earnings profile than the market is currently pricing in.
Result: Fair Value of $313.99 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on CUSIP’s role staying intact and on FactSet continuing to cross sell newer products to its 8,000 institutional clients without disruption.
Find out about the key risks to this FactSet Research Systems narrative.
Next Steps
With sentiment clearly split between risk and recovery, now is a good time to look through the numbers yourself and decide where you stand. After that, weigh both sides by checking the 4 key rewards and 1 important warning sign
Looking for more investment ideas?
If FactSet has caught your attention, do not stop here. Use the Simply Wall St screener to uncover other opportunities that could suit your style and goals.
- Target stronger value potential by scanning 59 high quality undervalued stocks with solid fundamentals already built into the filters.
- Prioritise resilience and capital protection by focusing on companies in the 68 resilient stocks with low risk scores that score well on risk checks.
- Hunt for underfollowed opportunities before the crowd by checking the screener containing 25 high quality undiscovered gems with quality metrics doing the early work for you.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com